speb/financial-data huggingface dataset:
MRD.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 64291000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 7070000.00
MRD.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 128756000.00
MRD.TO income_statement (annual, 2023-12-31) — Normalized Income: 83122263.48
MRD.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 48808000.00
MRD.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 24405000.00
MRD.TO income_statement (annual, 2023-12-31) — Operating Income: 119404000.00
MRD.TO income_statement (annual, 2023-12-31) — Operating Revenue: 222105000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 30662453.00
MRD.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 24660000.00
MRD.TO income_statement (annual, 2023-12-31) — Other Gand A: 8265000.00
MRD.TO income_statement (annual, 2023-12-31) — Other Income Expense: -12364000.00
MRD.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -23205000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 51696000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 53797000.00
MRD.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 11871000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Other Payable: 27219000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Other Properties: 6188000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
MRD.TO balance_sheet (annual, 2023-12-31) — Payables: 47663000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 47663000.00
MRD.TO income_statement (annual, 2023-12-31) — Pretax Income: 75777000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
MRD.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
MRD.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -21562000.00
MRD.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -718000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Receivables: 139699000.00
MRD.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 171938000.00
MRD.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1260000.00
MRD.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -95552000.00
MRD.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -8098000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Restricted Cash: 1719000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 1110389000.00
MRD.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 13407000.00
MRD.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
MRD.TO cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 7822000.00
MRD.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 965000.00
MRD.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 22637000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Share Issued: 30662453.00
MRD.TO income_statement (annual, 2023-12-31) — Special Income Charges: 51000.00
MRD.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1057000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1209578000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1209578000.00
MRD.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -4092736.52
MRD.TO income_statement (annual, 2023-12-31) — Tax Provision: 12797000.00
MRD.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.17
MRD.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 2998000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Assets: 2097473000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 1879752000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Debt: 670174000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1209578000.00
MRD.TO income_statement (annual, 2023-12-31) — Total Expenses: 195835000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 887895000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1159589000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 840232000.00
MRD.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 106870000.00
MRD.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 6989000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1246000.00
MRD.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -24235000.00
MRD.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -24235000.00
MRD.TO balance_sheet (annual, 2023-12-31) — Working Capital: 890221000.00
MRD.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 30420870.00
MRD.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -1.15
MRD.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 30420870.00
MRD.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -1.15
MRD.TO cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 2766000.00
MRD.TO cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 9040000.00
MRD.TO balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 63001000.00
MRD.TO income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: -27093000.00
MRD.TO cash_flow (quarterly, 2024-09-30) — Purchase Of Investment: 0.00
MRD.TO cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
MRD.TO income_statement (annual, 2024-12-31) — +Operating Expense: 30012000.00
MRD.TO income_statement (annual, 2024-12-31) — +Total Revenue: 349501000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 19257000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 175265000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 4826000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 48000000.00
MRD.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 30486390.00
MRD.TO income_statement (annual, 2024-12-31) — Basic EPS: 1.10
MRD.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 34690000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 4041000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 4041000.00
MRD.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -931000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 69866000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 54338000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 58111000.00
MRD.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -13400000.00
MRD.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -82085000.00
MRD.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 2685000.00
MRD.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 98626000.00
MRD.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 40500000.00
MRD.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 4850000.00
MRD.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -31342000.00
MRD.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 14008000.00
MRD.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -31342000.00
MRD.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 19226000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Common Stock: 69866000.00
MRD.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -13400000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1242630000.00
MRD.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -4623000.00
MRD.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 192115000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Current Assets: 995638000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 59486000.00
MRD.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 2962000.00
MRD.TO cash_flow (annual, 2024-12-31) — Deferred Tax: 2962000.00
MRD.TO cash_flow (annual, 2024-12-31) — Depreciation: 1247000.00
MRD.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1247000.00
MRD.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 277000.00
MRD.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1247000.00
MRD.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 277000.00
MRD.TO income_statement (annual, 2024-12-31) — Depreciation Income Statement: 277000.00
MRD.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 30678395.00
MRD.TO income_statement (annual, 2024-12-31) — Diluted EPS: 1.09
MRD.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 33528000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 0.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 0.00
MRD.TO income_statement (annual, 2024-12-31) — EBIT: 81644000.00
MRD.TO income_statement (annual, 2024-12-31) — EBITDA: 82891000.00
MRD.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 422000.00
MRD.TO cash_flow (annual, 2024-12-31) — End Cash Position: 54338000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Financial Assets: 2383000.00
MRD.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -82085000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 708047000.00
MRD.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 97695000.00
MRD.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 28439000.00
MRD.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 58000.00
MRD.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -27979000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 41039000.00
MRD.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 28444000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 11288000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 11288000.00
MRD.TO income_statement (annual, 2024-12-31) — Gross Profit: 157386000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 7367000.00
MRD.TO income_statement (annual, 2024-12-31) — Interest Expense: 26712000.00
MRD.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 26712000.00
MRD.TO income_statement (annual, 2024-12-31) — Interest Income: 2836000.00
MRD.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2836000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Inventory: 708047000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 1853969000.00
MRD.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 2685000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Investment Properties: 1044374000.00
MRD.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 37395000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 1293000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 1293000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 611339000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 611339000.00
MRD.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 37395000.00
MRD.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -101457000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 59829000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -4623000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Net Debt: 557001000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Income: 33528000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 33528000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 33528000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 33528000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 33528000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 33528000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 33528000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Interest Income: -29744000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -9154000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -3773000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -64062000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -64062000.00
MRD.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -29744000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 16543000.00
MRD.TO cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 9063000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Net PPE: 11288000.00
MRD.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -931000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1242630000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 67212000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 67212000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 5075000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 5075000.00
MRD.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 110812000.00
MRD.TO income_statement (annual, 2024-12-31) — Normalized Income: 50569711.35
MRD.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 98626000.00
MRD.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 28381000.00
MRD.TO income_statement (annual, 2024-12-31) — Operating Income: 127374000.00
MRD.TO income_statement (annual, 2024-12-31) — Operating Revenue: 252287000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 30367626.00
MRD.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 41039000.00
MRD.TO income_statement (annual, 2024-12-31) — Other Gand A: 13395000.00
MRD.TO income_statement (annual, 2024-12-31) — Other Income Expense: -42698000.00
MRD.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 17262000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 49795000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 68057000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 68057000.00
MRD.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -14777000.00
MRD.TO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -5054000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Other Payable: 32862000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Other Payable: 32862000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Other Properties: 5954000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 5954000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 3773000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 3773000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Payables: 59486000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 59486000.00
MRD.TO income_statement (annual, 2024-12-31) — Pretax Income: 54932000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MRD.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -5075000.00
MRD.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
MRD.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -16188000.00
MRD.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -931000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Receivables: 180151000.00
MRD.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 191145000.00
MRD.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1247000.00
MRD.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -101457000.00
MRD.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -4623000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Restricted Cash: 1329000.00
MRD.TO balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 1329000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: 1126899000.00
MRD.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 15049000.00
MRD.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 1302000.00
MRD.TO cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 7034000.00
MRD.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1291000.00
MRD.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 29735000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Share Issued: 30367626.00
MRD.TO income_statement (annual, 2024-12-31) — Special Income Charges: 58000.00
MRD.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1238000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1242630000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1242630000.00
MRD.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -10879288.65
MRD.TO income_statement (annual, 2024-12-31) — Tax Provision: 21404000.00
MRD.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.39
MRD.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 4886000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Assets: 2108553000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 1853969000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Debt: 611339000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1242630000.00
MRD.TO income_statement (annual, 2024-12-31) — Total Expenses: 222127000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 865923000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1112915000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 806437000.00
MRD.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 84216000.00
MRD.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 5868000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 7367000.00
MRD.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -27921000.00
MRD.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -27921000.00
MRD.TO balance_sheet (annual, 2024-12-31) — Working Capital: 936152000.00
MRD.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 7650000.00
MRD.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 50743000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 53916000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 141884000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5142000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
MRD.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 29505882.00
MRD.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.17
MRD.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 54338000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -74000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 69652000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 59472000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 59472000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -3332000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -71538000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 45452000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 31215000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -4284000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -4819000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 33071000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 23968000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 33071000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 5129000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 69652000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -3332000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1243488000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1103000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 23431000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 913386000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 53916000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 1149000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 1149000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 117000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 117000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 117000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 31350000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.16
MRD.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — EBIT: 13522000.00
MRD.TO income_statement (quarterly, 2025-03-31) — EBITDA: 13639000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 5000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 59472000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Financial Assets: 1783000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -71538000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 706891000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 31141000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -4098000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 1000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 4102000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 41022000.00
MRD.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 7650000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 27312000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 10709000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 0.00
MRD.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 5311000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5311000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Interest Income: 983000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 983000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 7758000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 706891000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1789514000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 45452000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Investment Properties: 1051295000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1534000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 546026000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 546026000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1534000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -67616000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 53901000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1103000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 486554000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Income: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 5016000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 5016000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -7601000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -2662000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 558000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -66082000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -66082000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -7601000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1021000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 47628000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 11244000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -72000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1243488000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 68362000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 68362000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 9536000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 2509527.22
MRD.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 31215000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -4099000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Operating Income: 19662000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 28066000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 30280470.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 41022000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 7650000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -3850000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 4748000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 58375000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 70390000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -7953000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Payables: 53916000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 53916000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 8211000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -3884000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -74000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 146017000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 23431000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 117000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -67616000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1103000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1006000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1127672000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 558000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 1222000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 2000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7650000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 30280470.00
MRD.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: 1000.00
MRD.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 316000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1243488000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1243488000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 1596527.22
MRD.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 3195000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.39
MRD.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 4133000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 2036083000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1789514000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 546026000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1243488000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 31081000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 792595000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1122697000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 738679000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 15808000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 3273000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
MRD.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4103000.00
MRD.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4103000.00
MRD.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 859470000.00
MRD.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 6755000.00
MRD.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 100139000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 45362000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 125253000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5498000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 27700000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 30241667.00
MRD.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.24
MRD.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 59472000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -380000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 69441000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 84139000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 84139000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -3323000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -22486000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 1590000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 47103000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -3001000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 6839000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 8691000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 12529000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 8691000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 26207000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 69441000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -3323000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1235032000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -1133000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 45099000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 950902000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 49846000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 22776000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 22776000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 420000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 420000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 420000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 30241667.00
MRD.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.24
MRD.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — EBIT: 45680000.00
MRD.TO income_statement (quarterly, 2025-06-30) — EBITDA: 46100000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -1540000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 84139000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 1860000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -22486000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 707670000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 46723000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 3081000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 115000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -2759000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 29431000.00
MRD.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 6755000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 55040000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 4335000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 4484000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 6095000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 6095000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Interest Income: 797000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 797000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 7021000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 707670000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1836080000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 1590000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Investment Properties: 1017912000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 13677000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 601048000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 601048000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 13677000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -13490000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 57946000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -1133000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 516909000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Income: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7258000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7258000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -4891000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -1399000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 3215000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 58124000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 187000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4891000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -76154000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 11165000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -226000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 57937000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1235032000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 91205000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 91205000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 49909000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 10495650.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 47103000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2966000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Operating Income: 48285000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 76696000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 30193350.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 29431000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 6755000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -3809000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 798000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 53238000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Payables: 49846000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 49846000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 39585000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -2210000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -380000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 131393000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 45099000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 420000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -13490000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -1133000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 0.00
MRD.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 1165000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1130662000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 3215000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 811000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 154000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6755000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 30193350.00
MRD.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -1050000.00
MRD.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 356000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1235032000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1235032000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -571350.00
MRD.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 32327000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
MRD.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 6140000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 2035077000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1836080000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 601048000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1235032000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 51854000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 800045000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1084175000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 750199000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 44154000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -407000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 4484000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -3809000.00
MRD.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -3809000.00
MRD.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 901056000.00
MRD.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 6195000.00
MRD.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 72543000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 61975000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 134220000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 5791000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 41050000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 30636957.00
MRD.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.46
MRD.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 84139000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -203000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 69247000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 79169000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 79169000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -3915000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -13555000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 12046000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -4853000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -28538000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 11889000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -9382000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -26031000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -9382000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -6362000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 69247000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -3915000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1245849000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1224000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 36555000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 1003997000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 63257000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -315000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -315000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 463000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 463000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 463000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 30636957.00
MRD.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.46
MRD.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 14093000.00
MRD.TO income_statement (quarterly, 2025-09-30) — EBIT: 26130000.00
MRD.TO income_statement (quarterly, 2025-09-30) — EBITDA: 26593000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 1392000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 79169000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Financial Assets: 1573000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -13555000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 745188000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5056000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 6299000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 10000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -3468000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 31025000.00
MRD.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6195000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 35988000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 10666000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1282000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 6251000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6251000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Interest Income: 1107000.00
MRD.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1107000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 7659000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 745188000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1839780000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 12046000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Investment Properties: 988893000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 9839000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 593931000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 593931000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 9839000.00
MRD.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -18255000.00
MRD.TO balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 65419000.00